Robert E. Coleman, MBBS, MD | Authors


Impact of Bone-Targeted Treatments on Skeletal Morbidity and Survival in Breast Cancer

August 15, 2016

Bone metastases are common in advanced breast cancer, and may be associated with serious morbidity, including fractures, pain, nerve compression, and hypercalcemia. Through optimum multidisciplinary management and the use of bone-targeted treatments, patients with advanced breast cancer have experienced a major reduction in skeletal complications, less bone pain, and an improved quality of life.